X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Clariant: Strongly facing odds - Views on News from Equitymaster
 
 
  • PRINT
  • E-MAIL
  • FEEDBACK
  • A  A  A
  • Aug 17, 2001

    Clariant: Strongly facing odds

    Clariant (India) Limited, (CIL), is a 51% subsidiary of the Swiss multinational Clariant AG. The company manufactures, develops and markets dyes, pigments, additives, masterbatches and specialty chemicals for textiles, leather, paper, plastics, paints and inks. The company has six major divisions-process and performance, pigments & additives, masterbatches, surfactants, fine chemicals and cellulose. Clariant (India) is one of the three global sourcing centers for Clariant Worldwide.

    (Rs m) FY00 FY01 % change
    Sales 2,528 2,802 10.8%
    Other Income 51 62 20.2%
    Expenditure 2,330 2,579 10.7%
    Operating Profit (EBDIT) 198 223 12.7%
    Operating Profit Margin (%) 7.8% 8.0%
    Interest (net) -20 -9 -55.0%
    Depreciation 26 30 15.8%
    Profit before Tax 243 264 8.4%
    Tax 89 101 13.5%
    Profit after Tax/(Loss) 154 163 5.4%
    Net profit margin (%) 6.1% 5.8%
    No. of Shares (eoy) (m) 11.9 11.9  
    Diluted Earnings per share* 13.0 13.7  
    P/E (at current price) 6.4 6.1  

    CIL managed a sales growth of 10.8% in FY01 despite poor market conditions. This growth was the result of the company's focus on new products, and an increase in the ratio of new products to sales from 14% in FY99 to 18% in FY01. CIL has entered into many new areas and has launched 100 new products during FY01. The most remarkable achievement of the company seems to be its stable operating margins, inspite of considerable increase in raw material costs during the year.

    Exports contributed around 29% of company's revenues with textile dyes accounting for majority of export revenues. However, the export market is extremely competitive with price pressures especially from China. However, in future, the company's exports are likely to show decent growth as it forms part of three main sourcing bases for its parent apart from China and Japan. To sustain growth rate and maintain its strong presence in this industry, CIL would focus on the textile chemicals, leather and masterbatches businesses. Masterbatches is one of the fastest and most rewarding businesses for the company. With new manufacturing facility for masterbatches coming in place, operating margins could witness a slight improvement in the current year.

    At the current market price of Rs 83, the stock is trading at a P/e 6 times its FY01 earnings. The company has declared a dividend of Rs 5 per share and hence the dividend yield at the current market price works out to be 6%. Though Clariant (India) seems to be fighting against all odds strongly, the outlook for the speciality chemicals industry is not expected to be encouraging in the near term. Majority of the speciality chemicals is consumed by the pharma industry. Minus the pharma industry demand, the speciality chemical industry continues to face poor demand growth. Overall growth in the segment is expected to be around 4-5%. Though Clariant India remains the leader in the industry and is expected to outperform the industry, the growth rates are expected to be unglamorous. Again the exports market is expected to remain sluggish with substantial capacity built up in China and lack of demand from European markets.

     

     

    Equitymaster requests your view! Post a comment on "Clariant: Strongly facing odds". Click here!

      
     

    More Views on News

    Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

    Aug 17, 2017

    Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

    More Views on News

    Most Popular

    Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

    Aug 7, 2017

    The data tells us quite a different story from the one the government is trying to project.

    A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

    Aug 10, 2017

    Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

    Aug 7, 2017

    Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

    More
    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
     

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms

    TRACK CLARIANT (I)

    • Track your investment in CLARIANT (I) with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
    • Add To MyStocks

    MARKET STATS